<?xml version="1.0" encoding="UTF-8"?>
<p>The EOCL (50 mg/kg, i.p.) caused significant (p &lt; 0.05) decrease and at 100 and 200 mg/kg, i.p., it caused significant decrease (p &lt; 0.01) in sleep latency {F
 <sub>(4,20)</sub> = 22.89} compared to control; Similarly, at the same dose levels, EOCL induced significant [p &lt; 0.05–0.01; F
 <sub>(4,20)</sub> = 21] prolongation of ketamine-induced total sleeping time (
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>A–B).
</p>
